Entacapone/levodopa/carbidopa/rasagilineLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2027卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67385-0

中图分类号：

学科分类号：

摘要：

引用

页码：196 / 196

共 50 条

[21] Levetiracetam/levodopa/carbidopa/propranololVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2020, 1817 (1) : 192 - 192
[22] Clonazepam/levodopa/carbidopa/oxycodoneConfusion, depression and lack of efficacy: case report
Reactions Weekly, 2022, 1901 (1) : 167 - 167
[23] Levodopa/carbidopa/entacapone in early Parkinson's disease
Reactions Weekly, 2020, 1798 (1) : 10 - 10
[24] Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (Stalevo) in Parkinson disease patients
Lyons, KE
Pahwa, R
CLINICAL NEUROPHARMACOLOGY, 2006, 29 (02) : 73 - 76
[25] Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference
Mueller, Thomas
PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 51 - 59
[26] Entacapone/levodopa/pramipexoleVisual hallucinations: case report
Reactions Weekly, 2018, 1730 (1) : 131 - 131
[27] Entacapone/levodopa/ropiniroleOrofacial dyskinesia: case report
Reactions Weekly, 2016, 1596 (1) : 87 - 87
[28] Levodopa/Levodopa/carbidopa overdoseDopamine dysregulation syndrome: case report
Reactions Weekly, 2016, 1621 (1) : 158 - 158
[29] Entacapone/levodopa/benserazide/levodopa/carbidopaDyskinesia and its aggravation: case report
Reactions Weekly, 2019, 1781 (1) : 158 - 158
[30] Comparison of 200 mg retarded release levodopa/carbidopa -: with 150 mg levodopa/carbidopa/entacapone application:: pharmacokinetics and efficacy in patients with Parkinson's disease
Mueller, T.
Ander, L.
Kolf, K.
Woitalla, D.
Muhlack, S.
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (11) : 1457 - 1462

← 1 2 3 4 5 →